Tarsons Products Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
TARSONS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tarsons Products announced its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025), along with confirming its 42nd AGM on September 22, 2025. Consolidated revenue from operations grew modestly to ₹913.64 million from ₹847.97 million in Q1 FY25 (about 7.7% growth), while standalone revenue rose to ₹712.79 million from ₹648.49 million (about 9.9% growth). However, profit after tax fell sharply — consolidated PAT dropped to ₹17.83 million from ₹40.16 million (down ~56%), and standalone PAT fell to ₹35.70 million from ₹64.61 million (down ~45%), with consolidated EPS slipping to ₹0.34 from ₹0.75. The profit decline was largely due to depreciation and amortisation nearly doubling (from ₹110.32 million to ₹199.36 million) and higher finance costs, reflecting recent capacity expansion and acquisitions. Statutory auditor Price Waterhouse Chartered Accountants LLP issued an unmodified (clean) limited review report on both standalone and consolidated results.
Despite healthy revenue growth, the steep drop in profits will likely concern investors, as margin pressure and higher depreciation from recent capex are weighing on near-term earnings. Additionally, shareholders should note the disclosed excess remuneration of ₹9.38 million to the Managing Director and ₹4.3 million to the Whole Time Director in FY25, for which the company is seeking a waiver via a special resolution at the upcoming AGM — a governance flag to watch.